Catheter-Associated Urinary Tract Infection
13
2
2
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.7%
1 terminated out of 13 trials
88.9%
+2.4% vs benchmark
15%
2 trials in Phase 3/4
38%
3 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (13)
Vitamin C Effectiveness in Preventing Urinary Tract Infections After Gynecological Surgeries
Adhesive Devices Versus Elastic Devices for Urinary Catheter Securement in Critically Ill Patients Experimental Study
Comparative Study Between Foley and T-Control® Catheter in Patients With Long-term Catheterization
Evaluation of Quality-of-Life Improvements Using UroShield Device
Efficacy of a Prepackaged Cleansing Cloth and Standardized Cleansing Protocol for Catheter Care at Reducing CAUTI Rates
Clinical Decision Support to Reduce Catheter Associated Urinary Tract Infections
Daily Chlorexidine Bath for Health Care Associated Infection Prevention
The Analysis of Factors Causing Indwelling Urinary Catheter-related Infections in ICU Patients and Their Nursing Strategies
Preventing Catheter-Associated Urinary Tract Infections With a Virtual Simulation Game
Effectiveness and Cost-effectiveness of the T-Control® Catheter in Patients With Acute Urine Retention
Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery
Smart Catheter: A Novel Biosensor for Early Detection of Catheter Associated Urinary Tract Infection
Prevention of Catheter-Associated Urinary Tract Infection in Incontinence and Reconstructive Pelvic Surgery Patients